Abiopharma

Kestrel Transportation, Inc. is a business focused on capitalizing on the convergence of several disruptive business technologies. This convergence of disruptive technologies will result in a paradigm shift in the way passengers and packages/freight are transported, as well as eliminating the old, conventional products and enterprises that have been used in the transportation industry. Kestrel Transportation intends to roll-up hard asset transportation companies and transition those companies into the new transportation paradigm using technology acquired from other acquisition targets, as well as intellectual property owned by and developed in-house by Kestrel Transportations technology group. Kestrel currently owns three essential U.S. Patents covering real-time scheduling of passenger and package transportation requests, which are the earliest patents covering this market segment and more applicable to the emerging transportation markets.

Additional info from OTC:
Kestrel Transportation, Inc. is a business focused on capitalizing on the convergence of several disruptive business technologies. This convergence of disruptive technologies will result in a paradigm shift in the way passengers and packages/freight are transported, as well as eliminating the old, conventional products and enterprises that have been used in the transportation industry. Kestrel Transportation intends to roll-up hard asset transportation companies and transition those companies into the new transportation paradigm using technology acquired from other acquisition targets, as well as intellectual property owned by and developed in-house by Kestrel Transportations technology group. Kestrel currently owns three essential U.S. Patents covering real-time scheduling of passenger and package transportation requests, which are the earliest patents covering this market segment and more applicable to the emerging transportation markets.